20022019
If you made any changes in Pure these will be visible here soon.

Personal profile

Ancillary activities

  • AM Pharma Bunnik | Bunnik | Pres. Commissaris | 2012-02-08 - present
  • AcTI Technologie en innovatie | Onbekend | Lid | 2012-02-08 - present
  • Artemis Foundation | Onbekend | Cofounder/Dir. | 2012-02-08 - present
  • Dynomics BV Rotterdam | Rotterdam | Commissaris | 2012-02-08 - present
  • Erasmus Universiteit | Rotterdam | Directeur | 2012-02-08 - present
  • Erasmus Universiteit Hope BV | Rotterdam | Commissaris | 2012-02-08 - present
  • Erasmus Universiteit ISAM BV | Rotterdam | Pres. Commissaris | 2012-02-08 - present
  • ErasmusMC, afdeling Virologie | Rotterdam | Hoogleraar | 2012-02-08 - present
  • Gezondheidsraad | Onbekend | Lid | 2012-02-08 - present
  • Medical Delta Multiplier BV | Delft/Leiden/Rotterdam | Oprichter/Dir. | 2012-02-08 - present
  • Medifocus Lelystad | Leystad | Directeur | 2012-02-08 - present
  • SAB Forbion Caital Partners | Onbekend | Lid | 2012-02-08 - present
  • SAB Probiotics Pfizer Consumer Health | Onbekend | Voorzitter | 2012-02-08 - present
  • Stichting Darmgezondheid | Onbekend | Oprichter/Dir. | 2012-02-08 - present
  • Viroclinics Biosciences BV | Rotterdam | Commissaris | 2012-02-08 - present

Ancillary activities are updated daily

Fingerprint Dive into the research topics where H.J.H.M. Claassen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Probiotics Medicine & Life Sciences
probiotics Agriculture & Biology
Vaccines Medicine & Life Sciences
Synbiotics Medicine & Life Sciences
Microbiota Medicine & Life Sciences
Research Medicine & Life Sciences
vaccines Agriculture & Biology
Industry Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

Open Access
civil society
driver
economics
performance
stakeholder

Dealing with the remaining controversies of probiotic safety

Van Den Nieuwboer, M. & Claassen, E., Jun 2019, In : Beneficial Microbes. 10, 6, p. 605-616 12 p.

Research output: Contribution to JournalArticleAcademicpeer-review

Probiotics
Safety
Critical Illness
Synbiotics
Health Services Needs and Demand

Policies and patenting to stimulate the biotechnology sector: Evidence from the Netherlands

Van Dongen, P., Tak, H. & Claassen, E., 1 Feb 2019, In : Science and Public Policy. 46, 1, p. 136-147 12 p.

Research output: Contribution to JournalArticleAcademicpeer-review

biotechnology
patent
Netherlands
evidence
policy

Probiotics for Childhood Functional Gastrointestinal Disorders: Do We Know What We Advise?

Browne, P. D., de Groen, A. C., Claassen, E. & Benninga, M. A., 25 Jun 2019, In : PharmaNutrition. 10, p. 1-7 7 p., 100160.

Research output: Contribution to JournalArticleAcademicpeer-review

Gastrointestinal Diseases
Probiotics
digestive system diseases
childhood
probiotics

Probiotics for improving quality of life in ulcerative colitis: Exploring the patient perspective

van der Waal, M. B., Flach, J., Browne, P. D., Besseling-van der Vaart, I., Claassen, E. & van de Burgwal, L. H. M., Mar 2019, In : PharmaNutrition. 7, p. 1-14 14 p., 100139.

Research output: Contribution to JournalArticleAcademicpeer-review

colitis
Probiotics
quality of life
Ulcerative Colitis
probiotics